Hesperidin+Diosmin

also known as HDC

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT06584799 Comparator	Dec 2024 → Jan 2025 overdue	pelvic congestion syndrome	Pirogov Russian National Research Medical University	Recruiting	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Hesperidin+Diosmin	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06584799 ↗
Known as	HDC	“Methods: VENOTREAT was a single-center, randomized, open-label study included 150 women with symptomatic PeVD, who were allocated for the 2-month therapy a once-daily intake...” PMID 40855727 ↗ Aug 2025